Skip to content
lifestyle.utv.ie
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Cue Biopharma, Inc.
Cue Biopharma Announces 1-for-30 Reverse Stock Split
May 3, 2026
Cue Biopharma to Present New Preclinical Data on Lead Autoimmune and Inflammatory Disease Candidate CUE-401 at IMMUNOLOGY2026
May 3, 2026
Cue Biopharma to Receive $7.5 Million Preclinical Milestone Payment from Boehringer Ingelheim Collaboration and License Agreement
May 2, 2026
Cue Biopharma Announces CEO Transition
April 30, 2026
Cue Biopharma to Host Virtual R&D Day Event on April 7, 2026
April 30, 2026
Cue Biopharma to Present New In vitro Data for CUE-401 at the 20th World Immune Regulation Meeting (WIRM) 2026
March 9, 2026
←
Previous Page
1
2